Inadequate Values from an Interferon-Gamma Release Assay for Smear-Negative Tuberculosis in a High-Burden Setting.

F. Liu,F-J. Du,H-Y. Jia,L-P. Pan,X. Zhang,A-Y. Xing,B-P. Du,Q. Sun,L-H. Nie,H. Li,R-M. Liu,Y. Ma,Z-D. Zhang

DOI: https://doi.org/10.5588/ijtld.14.0233

2014-01-01

The International Journal of Tuberculosis and Lung Disease

Abstract:OBJECTIVE:To examine the usefulness of an interferon-gamma release assay (IGRA) for the diagnosis of smear-negative tuberculosis (TB) in China.DESIGN:A total of 624 patients with presumed pulmonary TB were enrolled prospectively and categorised as smear-negative TB, smear-positive TB or no TB. All patients were tested using T-SPOT.TB.RESULTS:Both the smear-negative and smear-positive TB groups had significantly more spot-forming cells (SFCs) than the no TB group (all P < 0.001), while the smear-negative group had fewer SFCs than the smear-positive TB group (P < 0.001). The specificity of T-SPOT.TB was 60.4% (95%CI 53.4-67.1). The sensitivities of T-SPOT.TB in the smear-negative and smear-positive TB groups were respectively 81.4% (95%CI 75.7-86.0) and 93.2% (95%CI 87.6-96.4). The sensitivity in the smear-negative TB group was much lower than that in the smear-positive TB (P < 0.05).CONCLUSIONS:The sensitivity of T-SPOT.TB was lower due the paucibacillary nature of the samples, and the specificity was lower due to the high prevalence of latent tuberculous infection in the smear-negative TB patients. The T-SPOT.TB test should only be used as a supplementary test and not as a single test to rule in or rule out smear-negative TB.